rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Heather Knight

Director

Company insider

Files Form 4 as: Director, Waters; Chief Commercial Officer, Solventum; EVP, Chief Operating Officer, Baxter International.

In numbers

Trades disclosed
42
Buys
0
Sells
0
Bought
$0
Sold
$0
Companies
3
Companies where not an officer
1
First trade
1 Mar 2023
Last trade
30 Sep 2026
Last filed
2 Oct 2026

Companies traded

Where they are an officer
SOLV SolventumOfficer · Medical Devices · last 5 Mar 20260 buys · 0 sells
BAX Baxter InternationalOfficer · Medical Devices · last 6 Mar 20250 buys · 0 sells
Everywhere else they filed: board seats, 10% stakes, other companies
WAT WatersDirector · Life-science tools · last 30 Sep 20260 buys · 0 sells

Activity over time

Not enough dated trades to draw.

Every trade

TradedCompanyWhatAmount
30 Sep 2026filed 2 Oct 2026WAT WatersLife-science toolsSEC FORM 4 Code A—57.41 at $0.00filing
30 Jun 2026filed 2 Jul 2026WAT WatersLife-science toolsSEC FORM 4 Code A—63.03 at $0.00filing
30 Jun 2026filed 2 Jul 2026WAT WatersLife-science toolsSEC FORM 4 Code A—63.03 at $0.00filing
31 Mar 2026filed 2 Apr 2026WAT WatersLife-science toolsSEC FORM 4 Code A—68.44 at $0.00filing
31 Mar 2026filed 2 Apr 2026WAT WatersLife-science toolsSEC FORM 4 Code A—68.44 at $0.00filing
5 Mar 2026filed 9 Mar 2026SOLV Solventumoption or derivative · Medical DevicesSEC FORM 4 Code A—31,789 at $0.00filing
5 Mar 2026filed 9 Mar 2026SOLV Solventumoption or derivative · Medical DevicesSEC FORM 4 Code A—31,789 at $0.00filing
25 Feb 2026filed 27 Feb 2026WAT WatersLife-science toolsSEC FORM 4 Code A—23 at $0.00filing
25 Feb 2026filed 27 Feb 2026WAT Watersoption or derivative · Life-science toolsSEC FORM 4 Code A—57 at $0.00filing
25 Feb 2026filed 27 Feb 2026WAT Watersoption or derivative · Life-science toolsSEC FORM 4 Code A—57 at $0.00filing
25 Feb 2026filed 27 Feb 2026WAT WatersLife-science toolsSEC FORM 4 Code A—23 at $0.00filing
2 Jan 2026filed 5 Jan 2026WAT WatersLife-science toolsSEC FORM 4 Code A—307 at $0.00filing
2 Jan 2026filed 5 Jan 2026WAT Watersoption or derivative · Life-science toolsSEC FORM 4 Code A—828 at $0.00filing
2 Jan 2026filed 5 Jan 2026WAT Watersoption or derivative · Life-science toolsSEC FORM 4 Code A—828 at $0.00filing
2 Jan 2026filed 5 Jan 2026WAT WatersLife-science toolsSEC FORM 4 Code A—307 at $0.00filing
31 Dec 2025filed 5 Jan 2026WAT WatersLife-science toolsSEC FORM 4 Code A—59.79 at $0.00filing
31 Dec 2025filed 5 Jan 2026WAT WatersLife-science toolsSEC FORM 4 Code A—59.79 at $0.00filing
17 Nov 2025filed 18 Nov 2025SOLV Solventumoption or derivative · Medical DevicesSEC FORM 4 Code A—78,751 at $0.00filing
30 Sep 2025filed 2 Oct 2025WAT WatersLife-science toolsSEC FORM 4 Code A—77.88 at $0.00filing
30 Jun 2025filed 1 Jul 2025WAT WatersLife-science toolsSEC FORM 4 Code A—68.35 at $0.00filing

News

No headline names them, or the companies they trade most, lately.

Sectors

No trade we could place in a sector.

Related people

Julie FosterPresident, Front Line Care · President, Front Line Care at Baxter International, filing Form 4 there in the last year
James TeaffPresident, CCS · President, CCS at Baxter International, filing Form 4 there in the last year
Bryan C. HansonChief Executive Officer · Chief Executive Officer at Solventum, filing Form 4 there in the last year
Andrew P. HiderPresident and CEO · President and CEO at Baxter International, filing Form 4 there in the last year
Neil Craig ZieselmanSVP, Controller & CAO · SVP, Controller & CAO at Solventum, filing Form 4 there in the last year